Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

British Journal of Cancer

Volumn 110, Issue 9, 2014, Pages 2195-2200

  Daveau, C ^a   Baulies, S ^a   Lalloum, M ^a   Bollet, M ^a   Sigal Zafrani, B ^a   Sastre, X ^a   Vincent Salomon, A ^a   Tardivon, A ^a   Thibault, F ^a   Pierga, J Y ^a   Cottu, P ^a   Sablin, M P ^a   Rouzier, R ^a   Malhaire, C ^a   Mallon, P ^a   Reyal, F ^a  

^a INSTITUT CURIE   (France)

Author keywords

breast cancer; core biopsy; discordance; histological grade; predictive factors; tumour heterogeneity

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CONTROLLED STUDY; CORE NEEDLE BIOPSY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FRANCE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MITOSIS INDEX; NEEDLE BIOPSY; PARTIAL MASTECTOMY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; TISSUE SECTION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2;

EID: 84899981364     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.143     Document Type: Article

References (31)

1. Amat S, Penault-Llorca F, Cure H, Le Bouedëc G, Achard JL, Van Praagh I, Feillel V, Mouret-Reynier MA, Dauplat J, Chollet P (2002) Scarff-Bloom- Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol 20(4): 791-796.
2. Badoual C, Maruani A, Ghorra C, Lebas P, Avigdor S, Michenet P (2005) Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. Breast 14(1): 22-27.
3. Balaton AJ, Baviera EE, Galet B, Vaury P, Vuong PN (1995) [Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases]. Arch Anat Cytol Pathol 43(1-2): 93-100.
4. Balaton AL, Coindre JM, Collin F, Ettore F, Fiche M, Jacquemier J, Le Doussal V, Mandard AM, Mathieu MC, Migeon C, Simony-Lafontaine J, Treilleux I, Verriele V, Vilain MO, Zafrani B (1996) [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]. Ann Pathol 16(2): 144-148.
5. Burge CN, Chang HR, Apple SK (2006) Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? Breast 15(2): 167-172.
6. Cipolla C, Fricano S, Vieni S, Amato C, Napoli L, Graceffa G, Latteri S, Latteri MA (2006) Validity of needle core biopsy in the histological characterisation of mammary lesions. Breast 15(1): 76-80.
7. Crowe Jr JP, Patrick RJ, Rybicki LA, Grundfest SF, Kim JA, Lee KB, Rim A (2003) Does ultrasound core breast biopsy predict histologic finding on excisional biopsy? Am J Surg 186(4): 397-399.
8. D'Alfonso T, Liu YF, Monni S, Rosen PP, Shin SJ (2010) Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed. Am J Surg Pathol 34(4): 575-581.
9. Di Loreto C, Puglisi F, Rimondi G, Zuiani C, Anania G, Della Mea V, Beltrami CA (1996) Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur J Cancer 32A(10): 1693-1700.
10. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5): 403-410.
11. Guarneri V, Broglio K, Kau SW, Cristofanilli M, Buzdar AU, Valero V, Buchholz T, Meric F, Middleton L, Hortobagyi GN, Gonzalez-Angulo AM (2006) Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. J Clin Oncol 24(7): 1037-1044.
12. Harris GC, Denley HE, Pinder SE, Lee AH, Ellis IO, Elston CW, Evans A (2003) Correlation of histologic prognostic factors in core biopsies and therapeutic excision of invasive breast carcinoma. Am J Surg Pathol 27(1): 11-15.
13. Komaki K, Sano N, Tangoku A (2006) Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer 13(3): 249-253.
14. McIlhenny C, Doughty JC, George WD, Mallon EA (2002) Optimum number of core biopsies for accurate assessment of histological grade in breast cancer. Br J Surg 89(1): 84-85.
15. Morris EA, Liberman L, Trevisan SG, Abramson AF, Dershaw DD (2002) Histologic Heterogeneity of masses at percutaneous breast biopsy. Breast J 8(4): 187-191.
16. O'Leary R, Hawkins K, Beazley JC, Lansdown MR, Handby AM (2004) Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J Clin Pathol 57: 193-195.
17. Park SY, Kim KS, Lee TG, Park SS, Kim SM, Han W, Noh DY, Kim SW (2009) The accuracy of preoperative core biopsy in determining histological grade, hormone receptors and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 197(2): 266-269.
18. Penault-Llorca F, Vincent-Salomon A, Bellocq JP, Matthieu MC, Grogan GM, Treilleux I, Ettore F, Laberge-Le Couteulx S, Sigal B, Couturier J, Lacroix-Triki M, Antoine M, Balaton A, Baranzelli MC, Becette V, Blanc-Fournier C, Bibeau F, Brabencova E, Croce S, Fridman V, Génin P, Ghnassia JP, Jacquemier J, Poulet B, Roger P, Sagan C, Tas P, Trassard M, Verriele V, Arnould L. GEFPICS (2010) [Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]. Ann Pathol 30(5): 357-373.
19. Petit T, Wilt M, Velten M, Millon R, Rodier JF, Borel C, Mors R, Haegelé P, Eber M, Ghnassia JP (2004) Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomearase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. Eur J Cancer 40(2): 205-211.
20. Pettine S, Place R, Babu S, Williard W, Kim D, Carter P (1996) Stereotactic breast biopsy is accurate, minimally invasive, and cost effective. Am J Surg 171(5): 474-476.
21. Pijnappel RM, van Dalen A, Borel Rinkes IH, van den Tweel JG, Mali WP (1997) The diagnostic accuracy of core biopsy in palpable and nonpalpable breast lesions. Eur J Radiol 24(2): 120-123.
22. Pinder SE, Elston CW, Ellis IO (1996) The role of pre-operative diagnosis in breast cancer. Histopathology 28(6): 563-566.
23. Polyak K (2011) Heterogeneity in breast cancer. J Clin Invest 121(10): 3786-3788.
24. Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani S.R., Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4): 207-218.
25. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, Blamey RW, Ellis IO (2008) Prognostic significance of nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 26(19): 3153-3158.
26. Sharifi-Salamatian V, De Roquancourt A, Rigaut JP (2000) Breast carcinoma, intratumour heterogeneity and histological grading, using geostatics. Anal Cell Pathol 20(2-3): 83-91.
27. Usami S, Moriya T, Amari M, Suzuki A, Ishida T, Sasano H, Ohuchi N (2007) Reliability of prognostic factors in breast canrcinoma determined by core needle biopsy. Jpn J Clin Oncol 37(4): 250-255.
28. Van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, Bellot SM, Fijnheer J, van Gorp LH, Kwee WS (1992a) Reproducibility of mitosis counting in 2, 469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23(6): 603-607.
29. Van Diest PJ, Belien JA, Baak JP (1992b) An expert system for histological typing and grading of invasive breast cancer. First set up. Pathol Res Pract 188(4-5): 405-409.
30. Verkooijen HM, Peeters PH, Buskens E, Koot VC, Borel Rinkes IH, Mali WP, van Vroonhoven TJ (2000) Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer 82(5): 1017-1021.
31. Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA (2002) Assessment of histologic features and expression of biomarkers in predicting pathological response to anthracycline-based neoadjuvant chemotherapy in patients with breast cancer. Cancer 94(12): 3107-3114.